These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2519348)
21. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547 [TBL] [Abstract][Full Text] [Related]
22. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107 [TBL] [Abstract][Full Text] [Related]
23. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206 [TBL] [Abstract][Full Text] [Related]
24. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724 [TBL] [Abstract][Full Text] [Related]
25. Immunological disorders of type 1 diabetes mellitus. Ziegler M; Ziegler B Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194 [TBL] [Abstract][Full Text] [Related]
26. Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Lipton RB; Kocova M; LaPorte RE; Dorman JS; Orchard TJ; Riley WJ; Drash AL; Becker DJ; Trucco M Am J Epidemiol; 1992 Sep; 136(5):503-12. PubMed ID: 1442714 [TBL] [Abstract][Full Text] [Related]
27. HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. Serjeantson SW; Court J; Mackay IR; Matheson B; Rowley MJ; Tuomi T; Wilson JD; Zimmet P Hum Immunol; 1993 Oct; 38(2):97-104. PubMed ID: 8106272 [TBL] [Abstract][Full Text] [Related]
28. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry. Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975 [TBL] [Abstract][Full Text] [Related]
29. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211 [TBL] [Abstract][Full Text] [Related]
30. T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes. Dubois-LaForgue D; Carel JC; Bougnères PF; Guillet JG; Boitard C J Clin Immunol; 1999 Mar; 19(2):127-34. PubMed ID: 10226887 [TBL] [Abstract][Full Text] [Related]
33. ICA and organ-specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus--the JDS study. Kida K; Mimura G; Kobayashi T; Matsuura N; Toyota T; Kitagawa T; Hibi I; Ikeda Y; Tuchida I; Kuzuya H Diabetes Res Clin Pract; 1994 Apr; 23(3):187-93. PubMed ID: 7924880 [TBL] [Abstract][Full Text] [Related]
34. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297 [TBL] [Abstract][Full Text] [Related]
35. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375 [TBL] [Abstract][Full Text] [Related]
36. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
37. Islet cell antibodies in individuals at increased risk for IDDM. Schulz B; Witt S; Hildmann W; Ratzmann KP; Strese J; Keilacker H Exp Clin Endocrinol; 1984 Apr; 83(2):192-8. PubMed ID: 6373322 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological approaches to the prevention of autoimmune diabetes. Winter WE; House DV; Schatz D Drugs; 1997 Jun; 53(6):943-56. PubMed ID: 9179526 [TBL] [Abstract][Full Text] [Related]
39. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
40. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]